Korro Bio, Inc.

KRRO ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2023

Total Assets: $221.7M

Liabilities Breakdown FY2023

Total Liabilities: $51.8M